湖北能源(000883.SZ):湖北南漳抽水蓄能電站項目取得核准批覆
格隆匯2月6日丨湖北能源(000883.SZ)公佈,公司全資子公司湖北能源集團南漳張家坪抽水蓄能有限公司(以下簡稱張家坪抽蓄公司)於2023年2月6日收到《湖北省發展和改革委員會關於湖北南漳抽水蓄能電站項目核准的批覆》(鄂發改審批服務〔2023〕25號)。根據批覆內容,同意張家坪抽蓄公司作為項目公司投資建設湖北南漳抽水蓄能電站項目,項目總裝機180萬千瓦。
該項目的建設有利於滿足湖北省用電需求的增長和電力系統調峯需求,為電網安全穩定運行提供保障。同時項目的建設有助於提升公司清潔能源比重,優化產業結構。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.